Research Calls
- Upgrades:
- Alcon (ALC) upgraded to Outperform from Neutral at Robert W. Baird; tgt raised to $90
- Celsius (CELH) upgraded to Buy from Neutral at BofA Securities; tgt raised to $125
- CIBC (CM) upgraded to Buy from Hold at Canaccord Genuity
- Exact Sciences (EXAS) upgraded to Buy from Hold at Craig Hallum; tgt raised to $85
- Hain Celestial (HAIN) upgraded to Neutral from Underweight at Piper Sandler; tgt lowered to $16
- Halozyme Therapeutics (HALO) upgraded to Overweight from Neutral at Piper Sandler; tgt $46
- InterDigital (IDCC) upgraded to Buy from Neutral at BofA Securities; tgt raised to $105
- LegalZoom.com (LZ) upgraded to Market Perform from Underperform at MoffettNathanson; tgt $12
- MasterBrand (MBC) upgraded to Buy from Hold at Loop Capital; tgt raised to $13
- Nektar Therapeutics (NKTR) upgraded to Hold from Underperform at Jefferies; tgt lowered to $1
- Quotient (QUOT) upgraded to Buy from Hold at Craig Hallum; tgt raised to $4.50
- Tabula Rasa HealthCare (TRHC) upgraded to Outperform from Market Perform at SVB Securities; tgt raised to $10
- VTEX (VTEX) upgraded to Outperform from Market Perform at Itau BBA; tgt $6
- Y-mAbs Therapeutics (YMAB) upgraded to Outperform from Neutral at Wedbush; tgt raised to $13
- Downgrades:
- AdaptHealth (AHCO) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $11.30
- AdaptHealth (AHCO) downgraded to Hold from Buy at Stifel; tgt lowered to $11
- Amplitude (AMPL) downgraded to Mkt Perform from Outperform at William Blair
- Amplitude (AMPL) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $9
- Amplitude (AMPL) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
- Amyris (AMRS) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $1.25
- Anheuser-Busch InBev (BUD) downgraded to Hold from Buy at HSBC Securities
- Azenta (AZTA) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
- Bentley Systems (BSY) downgraded to Neutral from Buy at Rosenblatt; tgt raised to $47
- Dutch Bros (BROS) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $33
- Dutch Bros (BROS) downgraded to Neutral from Overweight at JP Morgan; tgt lowered to $32
- Expensify (EXFY) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt lowered to $8.50
- Health Catalyst (HCAT) downgraded to Mkt Perform from Outperform at Raymond James
- Health Catalyst (HCAT) downgraded to Neutral from Buy at Guggenheim
- Innovative Industrial Properties (IIPR) downgraded to Hold from Buy at Craig Hallum; tgt lowered to $80
- Lumentum (LITE) downgraded to Equal Weight from Overweight at Barclays; tgt lowered to $40
- Nikola Corporation (NKLA) downgraded to Market Perform from Outperform at TD Cowen; tgt lowered to $1
- PayPal (PYPL) downgraded to Hold from Buy at Edward Jones
- Prometheus Biosciences (RXDX) downgraded to Hold from Buy at Jefferies; tgt raised to $200
- Sealed Air (SEE) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $48
- Southern Copper (SCCO) downgraded to Sell from Neutral at Goldman; tgt raised to $66
- Others:
- 10x Genomics (TXG) initiated with an Overweight at Barclays; tgt $65
- Antero Midstream (AM) initiated with a Buy at UBS; tgt $14
- Bankwell Financial Group (BWFG) initiated with an Outperform at Hovde Group; tgt $26
- Braze (BRZE) initiated with an Overweight at Wells Fargo; tgt $34
- Cutera (CUTR) resumed with an Underweight at Piper Sandler; tgt $14
- Exelixis (EXEL) assumed with an Overweight at Piper Sandler; tgt $28
- GitLab (GTLB) initiated with a Neutral at DA Davidson; tgt $30
- Hess Midstream Partners (HESM) initiated with a Buy at UBS; tgt $37
- JFrog (FROG) initiated with a Buy at DA Davidson; tgt $25
- Oculis Holding AG (OCS) initiated with a Buy at Pareto; tgt $23
- Pacific Biosciences (PACB) initiated with an Equal Weight at Barclays; tgt $14
- Voyager Therapeutics (VYGR) initiated with a Buy at Truist; tgt $18